We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Focus Area Report for 2022 Expands on Oncology, Rare Disease Research
FDA Focus Area Report for 2022 Expands on Oncology, Rare Disease Research
In its 2022 Focus Areas of Regulatory Science report released last week, the FDA adds to its list of regulatory priorities research efforts in oncology and rare disease.